Condition
Glycopyrrolate
Total Trials
5
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 4 (1)
Trial Status
Completed2
Unknown2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06948409Active Not Recruiting
NMBA Reversal and Postoperative Urinary Retention
NCT06237478Not ApplicableCompletedPrimary
Effects of Glycopyrrolate on Heart Rate and Heart Rate Variability in Patients With Different Basic Heart Rate
NCT05693246Not ApplicableUnknownPrimary
Effect of Perioperative Use of Glycopyrrolate on Lung Function in Patients Under General Anesthesia
NCT06041984Phase 1UnknownPrimary
Antiperistaltic Effect and Safety of Glycopyrronium for Colonoscopic Polypectomy
NCT04401345Phase 4CompletedPrimary
Effect of Glycopyrrolate on Vasopressors Requirement for Non-elective Caesarean Section Under Spinal Anaesthesia
Showing all 5 trials